MXCT
MaxCyte Inc

415
Loading...
Loading...
News
all
press releases
MaxCyte, Inc. (MXCT) Reports Q2 Loss, Misses Revenue Estimates
MaxCyte (MXCT) delivered earnings and revenue surprises of -20.00% and -14.93%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
More News
News Placeholder
MaxCyte, Inc. (MXCT) Reports Q1 Loss, Tops Revenue Estimates
chainwire·4mo ago
News Placeholder
Glancy Prongay & Murray LLP Announces Investigation of MaxCyte, Inc. (MXCT)
Glancy Prongay & Murray LLP (GPM) announces its investigation of MaxCyte, Inc. (NASDAQ: MXCT) concerning the Company and its directors and officers possible violations of state laws. If you own...
Business Wire·7mo ago
News Placeholder
MaxCyte Director Executes Stock Options and Sells
MaxCyte (MXCT) has released an update. MaxCyte Inc., a leader in cell-engineering, has reported that their Non-Executive Director, John Johnston, h...
TipRanks Financial Blog·1y ago
News Placeholder
MaxCyte Announces Broker Name Change Post-Merger
MaxCyte (MXCT) has released an update. MaxCyte Inc., a leader in cell-engineering platform technologies, has announced a change of its Nominated Ad...
TipRanks Financial Blog·1y ago
News Placeholder
MaxCyte Signs Strategic Platform License with Be Biopharma to Support the Development of Engineered B Cell Medicines (BCMs)
Be Biopharma to use MaxCyte's Flow Electroporation technology and ExPERT platform within its Engineered B Cell Medicines programsROCKVILLE, Md., April 02, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc...
Globe Newswire·1y ago
News Placeholder
Commit To Buy MaxCyte At $2.50, Earn 6.7% Annualized Using Options
Investors considering a purchase of MaxCyte Inc (MXCT) shares, but cautious about paying the going market price of 4.26/share, might benefit from considering selling puts among the alternative...
Stock Options Channel·1y ago
News Placeholder
MaxCyte price target lowered by $2 at BTIG, here's why
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·1y ago
News Placeholder
MaxCyte affirms FY24 guidance
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·1y ago
News Placeholder
MaxCyte reports Q4 EPS (5c), consensus (7c)
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·1y ago

Latest MXCT News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.